WHO ICTRP trial
Urea treatment of hyponatremia in subarachnoid hemorrhage
CTIS2024-518532-36-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-518532-36-00 |
|---|---|
| Public title | Urea treatment of hyponatremia in subarachnoid hemorrhage |
| Scientific title | Urea treatment of hyponatremia in subarachnoid hemorrhage - 38RC19.189 |
| Primary sponsor | Centre Hospitalier Universitaire Grenoble Alpes |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | France |
| Conditions | hyponatremia during subarachnoid hemorrhage;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03] |
| Interventions | Product Name: ergytonyl placebo, Product Code:N/A, Pharmaceutical Form: N/A, Other descriptive name: N/A , Strength: , Pharmaceutical form of the placebo: N/A , Product Name: Urea, Product Code:PRD8548754, Pharmaceutical Form: ORAL POWDER… |
| Registration date | Mar 10, 2024 |
| Target size | 52 |
| Secondary IDs | NCT04552873;2020-001084-83 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: